...

qSTAR Medical

Besøg website

Om arbejdsgiveren

qSTAR Medical aims to improve the lives of patients suffering from End Stage Renal Disease (ESRD) by developing an innovative vascular access device featuring STAR® Biomaterial.

qSTAR Medical SAS was established in late 2011 as a spinout of Healionics USA with the support of OSEO France to develop a needle-free percutaneous port system for improved, pain-free and cost-effective vascular access for hemodialysis (HD) therapy.

There are approximately 20 million patients worldwide who suffer from Chronic Kidney Disease (CKD). An estimated 10% of these patients (2m) have progressed to the severe loss of kidney function defined as End Stage Renal Disease (ESRD) which requires life-sustaining thrice-weekly or daily dialysis therapy. Vascular access is the "Achilles heel" of hemodialysis therapy due to its high complication rates. ESRD patients need and deserve better vascular access options – qSTAR was created to help.

Arbejdsgiver placering

Find lignende arbejdsgivere

...
KTH Royal Institute of Technology Stockholm, Sverige 107 ledige stillinger
...
KU Leuven Leuven, Belgien 104 ledige stillinger
...
University of Luxembourg Luxembourg 100 ledige stillinger
...
Ghent University Gent, Belgien 71 ledige stillinger
...
University of Twente Enschede, Holland 62 ledige stillinger
Flere arbejdsgivere

Interessante artikler

...
5 Reasons to Pursue Your PhD at EMBL European Molecular Biology Laboratory (EMBL) 4 min læsning
...
Deciphering the Gut’s Clues to Our Health University of Turku 5 min læsning
...
Understanding Users to Optimise 3D Experiences Centrum Wiskunde & Informatica (CWI) 5 min læsning
...
Harnessing the Rhizosphere to Protect Our Soil Free University of Bozen - Bolzano 5 min læsning
Flere Stories